Paratek appoints new CFO
This article was originally published in Scrip
Paratek Pharmaceuticals has appointed Douglas Pagan to its executive leadership team as chief financial officer, effective 18 December 2014. Mr Pagan will report to Michael F Bigham, chair and chief executive officer of Paratek. Most recently, Mr Pagan was vice-president of finance at Acceleron Pharma, which he joined in 2008.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.